secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2026-10-01T20:30:27+00:00
Accession:  0001104659-26-112845
Event type: debt
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Fortress Biotech repays final $15M Oaktree debt, terminates $50M secured credit facility
--------------------------------------------------------------------------------

- On September 30, 2026 repaid $15.0M remaining principal under the Oaktree senior secured credit agreement, plus ~$435,000 accrued interest and a $150,000 prepayment fee.
- All liens and security interests in Company property were released and terminated; the Oaktree Agreement automatically terminated per its terms.
- Original $50.0M facility with Oaktree Fund Administration, LLC was entered July 25, 2024 and amended December 12, 2025 and February 22, 2026.
- Repayment clears all remaining indebtedness under the facility, leaving the company with no obligations to the Oaktree lenders.
- 8-K signed by CFO David Jin and dated October 1, 2026; no new guidance or financial results provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000110465926112845/0001104659-26-112845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000110465926112845/fbio-20260930x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-112845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer